- Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Expires: February 28, 2011 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Borland Scott

2. Date of Event Requiring Statement (MM/DD/YYYY) 7/21/2011

3. Issuer Name and Ticker or Trading Symbol

MAP Pharmaceuticals, Inc. [MAPP]

(Last) (First) (Middle)

2400 BAYSHORE PARKWAY SUITE 200

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
SVP, Neurology Franchise /

(Street)

MOUNTAIN VIEW, CA 94043

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	981	D
Common Stock	321	I	See Footnote ⁽¹⁾

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽²⁾	3/5/2017	Common Stock	1648	$3.363	D
Stock Option (Right to Buy)	⁽²⁾	5/1/2017	Common Stock	1589	$6.3897	D
Stock Option (Right to Buy)	⁽³⁾	1/21/2018	Common Stock	10000	$13.12	D
Stock Option (Right to Buy)	⁽³⁾	2/10/2019	Common Stock	51500	$10.37	D
Stock Option (Right to Buy)	⁽³⁾	2/1/2020	Common Stock	35000	$16.19	D
Resticted Stock Unit	⁽⁴⁾	2/1/2020	Common Stock	10000	⁽⁵⁾	D
Stock Option (Right to Buy)	⁽³⁾	1/25/2021	Common Stock	21000	$16.15	D
Restricted Stock Unit	⁽⁶⁾	1/25/2021	Common Stock	7000	⁽⁵⁾	D
Stock Option (Right to Buy)	⁽³⁾	6/6/2021	Common Stock	13750	$15.38	D
Restricted Stock Unit	⁽⁷⁾	6/6/2021	Common Stock	4500	⁽⁵⁾	D
Stock Option (Right to Buy)	⁽²⁾	3/6/2017	Common Stock	248	$3.363	I	See Footnote ⁽¹⁾
Stock Option (Right to Buy)	⁽²⁾	5/1/2017	Common Stock	4237	$6.3897	I	See Footnote ⁽¹⁾
Stock Option (Right to Buy)	⁽³⁾	1/21/2018	Common Stock	2500	$13.12	I	See Footnote ⁽¹⁾
Stock Option (Right to Buy)	⁽³⁾	2/10/2019	Common Stock	5000	$10.37	I	See Footnote ⁽¹⁾
Stock Option (Right to Buy)	⁽³⁾	2/1/2020	Common Stock	4375	$16.19	I	See Footnote ⁽¹⁾
Stock Option (Right to Buy)	⁽³⁾	1/25/2021	Common Stock	1800	$16.15	I	See Footnote ⁽¹⁾
Restricted Stock Unit	⁽⁶⁾	1/25/2021	Common Stock	600	⁽⁵⁾	I	See Footnote ⁽¹⁾

Explanation of Responses:
( 1)	Shares held by the spouse of the reporting person. The reporting person disclaims beneficial beneficiary ownership of the shares except to the extent of his pecuniary interest therein.
( 2)	Fully exercisable.
( 3)	The option is exercisable as it vests: 25% of the total number of option shares vests and becomes exercisable on the first anniversary of the vesting commencement date. Thereafter, 1/48th of the total number of option shares becomes exercisable cumulatively on each monthly anniversary for 36 months so that the entire number of option shares becomes fully vested.
( 4)	Vesting of the RSU award is performance-based.
( 5)	Each RSU represents a contingent right to receive one share of MAP common stock.
( 6)	25% of the total number of RSUs vests and becomes payable on each anniversary of January 26, 2011, such that all RSUs subject to this award shall be fully vested on January 26, 2015.
( 7)	25% of the total number of RSUs vests and becomes payable on each anniversary of June 07, 2011, such that all RSUs subject to this award shall be fully vested on June 07, 2015.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Borland Scott 2400 BAYSHORE PARKWAY SUITE 200 MOUNTAIN VIEW, CA 94043			SVP, Neurology Franchise

Signatures
/s/ Scott Borland		8/4/2011
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.